Viewing Study NCT03278158


Ignite Creation Date: 2025-12-25 @ 12:07 AM
Ignite Modification Date: 2026-01-24 @ 8:03 AM
Study NCT ID: NCT03278158
Status: COMPLETED
Last Update Posted: 2019-03-22
First Post: 2017-08-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single-dose Trial to Investigate the Safety and Tolerability of XEN-D0501 in Patients With Diabetes Mellitus Type 2
Sponsor: Pila Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tolerability View
None safety View